Chin Hyok Lee
CIK: 0002010805
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)2 (66.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Lee Chin Hyok
Lee Chin Hyok (SEC CIK 0002010805) files insider reports with the SEC as Chief Medical Officer of Lycia Therapeutics, Inc. (LYCA) and Chief Medical Officer of Allakos Inc. (ALLK).
Signal8 holds 4 ownership filings by Lee Chin Hyok (1 Form 3, 3 Form 4), filed between Sep 11, 2024 and Oct 26, 2026. Those filings report 3 transactions, from Sep 9, 2024 to Aug 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lee Chin Hyok's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Lee Chin Hyok
Other insiders filing for Lycia Therapeutics, Inc. (LYCA)
- Venrock Healthcare Capital Partners III, L.P., 10% Owner
- Versant Ventures VII GP, L.P., 10% Owner
- Fischer Laurent, Director
- Henderson Jane, Director
- RIEFLIN WILLIAM JL, Director
- Touami Sofia, Chief Business Officer